A Foot In The Door Or One Foot In The Grave? The Role Of Real World Evidence In Cancer Drugs Fund Re-Appraisals

May 16, 2018

Educational poster presented at ISPOR 16th Annual International Meeting, Baltimore, May 2018

Educational poster presented at ISPOR 16th Annual International Meeting, Baltimore, May 2018

Previous Article
Emerging Privates: Identifying The Major Markets For Private Healthcare Expenditure
Emerging Privates: Identifying The Major Markets For Private Healthcare Expenditure

Next Article
Squaring The Circle? Using Real World Data From Early Access Programs To Inform Pricing And Reimbursement Decision Making
Squaring The Circle? Using Real World Data From Early Access Programs To Inform Pricing And Reimbursement Decision Making

×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!